###### Strengths and limitations of this study

-   This is a retrospective cohort study using real-world clinical data to evaluate the characteristics and risk factors for anastomotic leakage after oesophagectomy from the perspective of the level of anastomosis.

-   Detailed perioperative parameters allow us to better elucidate the risk factors for predicting anastomotic leakage and to address the impact of the level of anastomosis on other surgical outcomes.

-   The retrospective collection of clinical factors is subject to recall bias and other biases.

Introduction {#s1}
============

Oesophageal carcinoma is one of the most common malignant gastrointestinal tumours in China, carrying a high mortality risk if not treated immediately and properly.[@R1] Despite extensive advances in the treatment strategies, oesophagectomy remains the standard therapy for curable patients with oesophageal carcinoma.[@R2] However, anastomotic sites are prone to leakage with a reported incidence ranging from 5% to up to 30%,[@R3] which leads the cause of morbidity and mortality in patients undergoing surgery for oesophageal cancer.[@R2] As a serious complication, anastomotic leakage accounts for up to 20% of readmission[@R4] and increases the risk of recurrence and reduces long-term survival.[@R5]

At present, cervical oesophagogastric anastomoses (COA) and intrathoracic oesophagogastric anastomoses (IOA) have enjoyed widespread adoption and acceptance in the maintenance of the anatomical and functional integrity of gastrointestinal tract with esophagectomy. Recently, there is a growing focus on the potential impacts of anastomotic level on anastomotic leakage. Some studies point outed the association of IOA with a low leakage rate but potentially high morbidity and mortality, and the association of COA with a higher leakage rate but more manageable complications.[@R5] However, there has been no consensus yet on these findings due to the diversity of sample size and study design. Although diabetes has been identified as predictors of leakage, other preoperative risk factors for leakage remains controversial,[@R7] and knowledge is little regarding the effect of operative factors on the risk of anastomotic leakage after oesophagectomy.

The aim of our study was to investigate the consequences of intrathoracic versus cervical anastomosis after oesophagectomy and identify predisposing perioperative risk factors for development of leakage following oesophageal cancer surgery in a large number of patients, which contributes to providing important information for better selection of patients and to allowing the surgeon to create a patient-tailored approach for appropriate decision-making.

Materials and methods {#s2}
=====================

Study design, setting and participants {#s2a}
--------------------------------------

Between 1 January 2010 and 31 December 2016, all patients with oesophageal cancer of the distal oesophagus or gastro-oesophageal junction undergoing elective esophagectomy with a curative intent for oesophageal carcinoma with COA and with IOA were included and analysed retrospectively at Taizhou City Hospital of Traditional Chinese Medicine. All patients provided written informed consent.

Patient and public involvement {#s2b}
------------------------------

Patients and public were not involved in this study.

Surgical procedure {#s2c}
------------------

The standard operation consisted of en bloc oesophagectomy with two-field or three-field lymph node dissection via conventional thoracotomy or video-assisted thoracic surgery, gastric tube reconstruction and final oesophagogastric anastomosis using the stomach in all patients as described previously.[@R10] All patients underwent laparoscopic or open gastric mobilisation. Laparoscopic mobilisation was the same as in the open approach, with the stomach mobilised on the greater curvature of stomach and right gastroepiploic arcades using ultrasonic shears. Both procedures included partial division of the lesser curvature of the stomach with a linear stapler to create a gastric tube.[@R12]

The anastomosis was usually established on the posterior wall of the gastric tube by a mechanical procedure using a circular or liner stapler, hand-sewn procedure or semimechanical procedure, in an end-to-end, end-to-side or side-to-side fashion if appropriate. Anastomosis was fashioned manually in two layers using a running inner layer suture and an interrupted outer layer. Cervical anastomosis was done at the level of thyroid on the interior sternocleidomastoid muscle of the left neck, and intrathoracic anastomosis was done in the upper chest or around the level of azygos arch depending on the location of tumour. The length of the remnant cervical oesophagus was typically 2--4 cm.[@R13] Both cervical and intrathoracic anastomosis was performed through the oesophageal bed in the posterior mediastinum. Pyloroplasty was left to the surgeon's discretion. Cervical lymph node dissection was selectively performed on the basis of preoperative ultrasonic, physical and radiological examinations.

Specific surgical approaches were performed mainly based on the clinical staging, pathological anatomy and biological characteristics. Besides, the conditions of all patients and the most suitable surgical approach that could be performed were discussed at a joint medical and surgical thoracic conference, while taking into consideration the willingness of patients and local experience of surgeons and the surgeons' preference.

Data collection and outcome measures {#s2d}
------------------------------------

Data of the patients collected included the demographics, preoperative risk factors, intraoperative data in-hospital, 30 day and short-term conditions. Variables in the study were defined according to the Society of Thoracic Surgeons database. Carcinoma of oesophagus was characterised according to the tumour node metastasis classification system of the American Joint Committee for Cancer Staging (seventh edition).[@R14] Primary outcomes were the rate of anastomotic leakage, operative morbidity, and operative mortality. In brief, the definition and classification of anastomotic leakage as well as other adverse events was same as described previously,[@R15] according to the Esophagectomy Complications Consensus Group (ECCG).[@R16] Taking into account the integrative assessment of radiographic examination, clinical sign and symptom and therapeutic schemes, we define and quantise the patterns and magnitude of dysphagia, dumping and regurgitation. The leak-related reoperation was defined as the incidence of reoperations mainly caused by leakage within 30 days after surgery.

Statistical analysis {#s2e}
--------------------

Continuous variables were reported as means±SD and two-sample t-test or Mann-Whitney U-test were used to compare groups in univariate analysis. Categorical variables were reported as proportions and Pearson's χ^2^ test was used to compare groups in univariate analysis. Univariate analyses were performed to determine associations of clinical and pathological variables with overall anastomotic leak, major leak and stricture as endpoints. Those variables with p\<0.25 from univariate analyses were entered into multivariable logistic regression analyses. Backward stepwise elimination (using highest p value as an elimination criterion) was used to derive the final multivariable logistic regression models to determine an adjusted effect size of variables on outcome. The results of multivariable analyses were expressed as OR with a 95% CI and p value. A value of p\<0.05 was considered significant. All statistical analyses were performed using Stata V.14.

Results {#s3}
=======

Study population characteristics {#s3a}
--------------------------------

During the 6-year study period, a total of 584 patients undergoing oesophagectomy were identified through our medical records. Among them, 126 patients were excluded due to incomplete data, incorrect operation classification and uninterested population who underwent concomitant other cancer operations. Finally, 458 consecutive patients (360 men and 55 women) were included in the analysis. Their median age at the time of surgery was 61 years (range: 26--81 years). To compare the effect of level of anastomotic site on postoperative leakage, patients were divided into two groups (COA group: n=126 (27.5%) and IOA group: n=332 (72.5%)). Of these patients, anastomotic leakage developed in 55 patients (12.0%), among whom three returned to the operating room for control of the leak and 51 were managed with conservative treatment (such as placing surgical drains, fasting, nutritional support, suction of gastric fluids and so on).

Comparison of oesophagogastric anastomosis {#s3b}
------------------------------------------

The baseline and clinical characteristics of patients according to oesophagogastric anastomotic level (COA or IOA) are presented in [table 1](#T1){ref-type="table"}. The demographics, comorbidities, preoperative therapy, oncological characteristics and postoperative histological findings were comparable between both groups in all covariates with all p values \>0.05 ([table 1](#T1){ref-type="table"}).

###### 

Comparison of clinical and pathological characteristics between groups

  Characteristics                COA (n=126)   IOA (n=332)   t/χ^2^   P values
  ------------------------------ ------------- ------------- -------- ----------
  Age (years)                    63.4±7.5      62.8±8.0      0.98     0.328
  Female gender (%)              26 (20.6)     59 (17.8)     0.49     0.482
  BMI (kg/m^2^)                  26.4±4.8      25.8±5.1      0.83     0.408
  Alcohol history (%)            79            174           1.29     0.256
  Smoking history (%)            78            221           0.876    0.349
  Comorbidities                                                       
   Diabetes mellitus             18 (14.3)     50 (15.1)     0.04     0.825
   Hypertension                  50 (39.7)     125 (40.7)    0.16     0.690
   Coronary artery disease       15 (11.9)     43 (12.9)     0.09     0.764
   Renal dysfunction             3 (2.4)       7 (2.1)       0.03     0.859
   COPD                          16 (12.7)     49 (14.6)     0.32     0.573
   Chronic hepatopathy           6 (4.7)       17 (5.1)      0.02     0.875
   Cerebral stroke               3 (2.4)       8 (2.5)       0.01     0.986
   Atrial fibrillation           7 (5.6)       20 (6.0)      0.04     0.849
   Peptic ulcer disease          14 (11.1)     26 (7.8)      1.23     0.267
  ASA classification (%)                                              
   1                             12 (9.5)      26 (7.8)      0.34     0.558
   2                             97 (77.0)     222 (66.9)    0.25     0.617
   3                             18 (14.3)     81 (24.4)     1.30     0.254
  Tumour location (%)                                                 
   Gastro-oesophageal junction   89 (70.6)     268 (80.7)    5.40     0.020
   Distal oesophagus             37 (29.4)     64 (19.3)              
  Histological type (%)                                               
   Squamous cell carcinoma       28 (22.2)     77 (23.2)     0.05     0.826
   Adenocarcinoma                90 (71.4)     249 (75.0)    0.60     0.437
   Other                         2 (1.6)       6 (1.8)       0.03     0.873
  Pathological stage (%)                                              
   Stage I                       19 (15.1)     56 (16.9)     0.21     0.645
   Stage II                      41 (32.5)     112 (33.7)    0.06     0.809
   Stage III                     66 (51.6)     164 (49.1)    0.32     0.569
  Neoadjuvant therapy (%)                                             
   None                          64 (50.8)     156 (47.0)    0.53     0.467
   Chemotherapy                  18 (14.3)     59 (17.8)     0.79     0.374
   Radiotherapy                  5 (4.0)       11 (3.3)      0.12     0.733
   Chemoradiotherapy             39 (30.9)     106 (31.9)    0.41     0.841

Values are expressed as mean±SD or number of patients (n, %).

P value refers to comparison between patients with COA and IOA.

ASA, American Society of Anesthesiologists; BMI, body mass index; COA, cervical oesophagogastric anastomosis; COPD, chronic obstructive pulmonary disease; IOA, intrathoracic oesophagogastric anastomosis.

The intraoperative characteristics between the two groups are shown in [table 2](#T2){ref-type="table"}. The differences in abdominal conversion rate, thoracic conversion rate, R0-resection rate and complete pathological response and between groups were homogeneous with all p values \>0.05, except for surgical pathway, surgical procedure, anastomotic mode and anastomotic configuration, as well as operation time, blood loss and lymph nodes ([table 2](#T2){ref-type="table"}).

###### 

Comparison of intraoperative and pathological characteristics between groups

  Characteristics                      COA (n=126)   IOA (n=332)   t/χ^2^   P values
  ------------------------------------ ------------- ------------- -------- ----------
  Surgical pathway, %                                                       
   Sweet                               0 (0)         89 (26.8)     41.83    0.001
   McKeown                             126 (100)     0 (0)         457.5    0.001
   Ivor Lewis                          0 (0)         243 (73.2)    196.2    0.001
  Surgical procedure,%                                                      
   Open esophagectomy                  82 (65.1)     180 (54.2)    4.39     0.036
   Minimally invasive esophagectomy    44 (34.9)     152 (45.8)             
    Thoracoscopic oesophagectomy       17 (13.5)     24 (7.2)               
    Laparoscopic oesophagectomy        11 (8.7)      27 (8.1)               
    Thoracoscopic--laparoscopic        16 (12.6)     101 (30.4)             
  Anastomotic configuration, %                                              
   End to end                          98 (77.8)     0 (0)         327.8    0.001
   End to side                         7 (5.6)       176 (53.0)    85.5     0.001
   Side to side                        21 (16.7)     156 (47.0)    35.34    0.001
  Anastomotic fashion, %                                                    
   Handsewn                            45 (35.7)     33 (9.9)      42.85    0.001
   Stapled                             32 (25.4)     201 (60.5)    45.04    0.001
   Semimechanical                      49 (38.9)     98 (29.5)     3.67     0.055
  Abdominal conversion rate, %         4 (3.2)       8 (2.4)       0.21     0.648
  Thoracic conversion rate, %          1 (0.8)       5 (1.5)       0.36     0.550
  Median operation time, min           295.4±39.5    286.1±41.4    2.15     0.032
  Median blood loss, mL                232.0±38.3    223.8±39.8    1.97     0.048
  R0-resection rate, %                 119 (94.4)    321 (96.7)    1.21     0.271
  Complete pathological response, %    30 (23.8)     73 (22.0)     0.17     0.677
  Lymph node dissection                21.1±5.4      19.5±5.2      2.86     0.004
  Cervical lymph node dissection       2.4±0.6       0              NA      NA
  Length of remnant oesophagus\*, cm   3.6±0.8       8.2±1.9       36.42    0.001

Values are expressed as mean±SD or number of patients (n, %).

P values refers to comparison between patients with COA and IOA.

\*The length of remnant oesophagus was measured on the radiological or endoscopic examinations postoperatively.

COA, cervical oesophagogastric anastomosis; IOA, intrathoracic oesophagogastric anastomosis; NA, not applicable.

Postoperative morbidity and mortality results between groups are demonstrated in [table 3](#T3){ref-type="table"}. Overall, COA is associated with a higher leakage rate than IOA (16.6% vs 10.2%), but the difference was statistically insignificant (p=0.058). IOA is superior to COA with regard to postoperative functional morbidity including recurrent laryngeal nerve injury, dysphagia, regurgitation, endoscopy for suspected anastomotic stricture and anastomotic stricture requiring dilatation. The incidence of thoracic complications, major adverse cardiovascular and cerebrovascular events and renal insufficiency were comparable between the groups. Regarding the secondary intervention, radiological reintervention was significantly more in the IOA group than in the COA group (p=0.022), but no statistical differences were found in terms of chest tube and endoscopic intervention (p\>0.05). No statistically significant differences were found between groups regarding the reintubation, hospital and intensive care unit length of stay, leak-related reoperation, in-hospital mortality and both 30 day all cause and leak-related mortality rates ([table 3](#T3){ref-type="table"}).

###### 

Comparison of postoperative morbidity and mortality between groups

  Morbidity and mortality                    COA (n=126)   IOA (n=332)   t/χ^2^   P values
  ------------------------------------------ ------------- ------------- -------- ----------
  Anastomotic leakage, %                     21 (16.6)     34 (10.2)     3.19     0.058
   Grade 1                                   3 (2.3)       7 (2.1)       0.03     0.859
   Grade 2                                   13 (10.3)     18 (5.4)      3.46     0.063
   Grade 3                                   5 (4.0)       9 (2.7)       0.26     0.521
  Functional morbidity, %                                                         
   Recurrent laryngeal nerve injury          13 (10.3)     4 (1.2)       21.18    0.001
   Endoscopy for suspected stricture         41 (32.5)     72 (21.7)     5.78     0.016
   Stricture requiring dilatation            25 (19.8)     45 (13.5)     4.44     0.035
   Dysphagia                                 44 (34.9)     69 (20.7)     3.33     0.020
   Regurgitation, %                          18 (14.3)     26 (7.8)      4.37     0.037
  Thoracic complications, %                                                       
   Pneumonia                                 40 (31.7)     99 (29.8)     0.16     0.689
   Empyema                                   10 (7.9)      28 (8.4)      0.03     0.863
   Pneumothorax                              10 (7.9)      33 (9.9)      0.43     0.512
   Mediastinitis                             5 (3.9)       16 (4.8)      0.15     0.698
   Chyle leakage                             8 (6.3)       26 (7.8)      0.29     0.589
   Reintubation rate                         18 (14.3)     49 (14.8)     0.02     0.898
  MACCE, %                                                                        
   Sustained arrhythmia                      26 (20.6)     79 (23.7)     0.52     0.473
   Myocardial infarction                     2 (1.6)       5 (1.5)       0.001    0.950
   Cardiac arrest                            1 (0.8)       1 (0.3)       0.51     0.476
   Pericarditis                              1 (0.8)       2 (0.6)       0.05     0.821
   Heart failure                             5 (3.9)       14 (4.2)      0.01     0.905
   Cerebrovascular accident                  3 (2.4)       7 (2.1)       0.03     0.859
   Acute kidney injury, %                    26 (20.6)     93 (28.0)     2.58     0.108
   Acute kidney injury needing dialysis, %   6 (4.7)       15 (4.5)      0.01     0.911
  Secondary intervention rate, %                                                  
   Chest tube (bedside)                      7 (5.5)       17 (5.1)      0.03     0.852
   Radiological intervention                 10 (7.9)      54 (16.2)     5.26     0.022
   Endoscopic intervention                   21 (16.6)     48 (14.4)     0.35     0.556
  Median length of stay                                                           
   Intensive care unit (hour)                75.9±6.4      74.8±6.7      1.62     0.105
   Hospital (days)                           12.7±3.1      12.1±2.9      1.88     0.060
  Readmission rate, %                                                             
   Intensive care unit                       20 (15.9)     68 (20.4)     1.25     0.264
   Hospital                                  16 (12.6)     47 (14.1)     0.16     0.686
   Leak-related reoperation, %               5 (4.0)       10 (3.0)      0.26     0.608
  Mortality, %                                                                    
   In-hospital                               4 (3.2)       10 (3.0)      0.01     0.928
   30 day all-cause mortality                5 (3.9)       12 (3.6)      0.03     0.858
   30 day leak-cause mortality               2 (1.6)       4 (1.2)       0.10     0.748

Values are expressed as mean±SD or number of patients (n, %).

P value refers to comparison between patients with COA and IOA.

COA, cervical oesophagogastric anastomosis; IOA, intrathoracic oesophagogastric anastomosis; MACCE, major adverse cardiovascular and cerebrovascular events.

Risk factors for anastomotic leakage {#s3c}
------------------------------------

The preoperative and operative variables between patients with and without anastomotic leakage are summarised in [table 4](#T4){ref-type="table"}. We included all factors identified as p\<0.1 by univariate analysis (preoperative chemoradiotherapy, tumour location, tumour histology, surgical method, operation time and surgical procedure) and our interested clinical factors (the level of anastomotic site) into multivariate logistic regression analysis to identify independent risk factors for overall anastomotic leakage as endpoint.

###### 

Comparison of preoperative and intraoperative characteristics in patients with and without AL

  Characteristics                                     Total (458)     Without AL (n=403)   With AL (n=55)   tχ^2^/z   P values
  --------------------------------------------------- --------------- -------------------- ---------------- --------- ----------
  Age \>60 years                                      293             251                  42               4.15      0.042
  Female gender                                       85              71                   14               1.96      0.161
  Obesity                                             122             102                  20               4.25      0.039
  Alcohol history                                     253             225                  38               3.47      0.062
  Smoking history                                     299             257                  42               3.38      0.066
  Comorbidities                                                                                                       
   Diabetes mellitus                                  68              54                   14               5.55      0.018
   Hypertension                                       175             150                  25               1.39      0.239
   Coronary artery disease                            58              47                   11               3.04      0.081
   Renal dysfunction                                  10              8                    2                0.62      0.432
   COPD                                               65              55                   10               0.82      0.367
   Chronic hepatopathy                                23              18                   5                2.17      0.141
   Cerebral stroke                                    11              8                    3                2.48      0.115
   Atrial fibrillation                                27              23                   6                2.20      0.138
   Peptic ulcer disease                               40              32                   8                2.64      0.098
  ASA classification                                                                                                  
   1/2/3                                              38/319/99       35/281/85            3/38/14          0.967     0.333
  Tumour location                                                                                                     
   Gastro-oesophageal junction                        357             320                  37               4.13      0.042
   Distal oesophagus                                  101             83                   18                         
  Histological type                                                                                                   
   SCC/Adenocarcinoma/Other                           105/345/8       94/304/8             11/44/0          0.254     0.799
  Pathological stage                                                                                                  
   Stage I/2/3                                        75/153/230      68/138/199           7/17/31          1.066     0.286
  Neoadjuvant therapy                                                                                                 
   None/chemotherapy/radiotherapy/chemoradiotherapy   220/77/16/145   194/68/14/127        26/9/2/18        0.165     0.869
  Anastomotic level                                                                                                   
   COA/IOA                                            126/332         105/298              21/34            3.56      0.059
  Surgical pathway                                                                                                    
   Sweet/Ivor Lewis/McKeown                           89/126/243      83/113/206           6/13/37          2.221     0.026
  Surgical procedure                                                                                                  
   Open                                               262             238                  24               4.69      0.030
   Minimally invasive                                 196             165                  31                         
  Anastomotic configuration                                                                                           
   End to end/end to side/side to side                98/183/177      87/161/155           11/22/22         0.282     0.778
  Anastomotic mode                                                                                                    
   Handsewn/stapled/semimechanical                    78/233/147      63/210/130           15/23/17         2.913     0.014
  Stapled                                                                                                             
   Circular                                           80              72                   8                0.07      0.786
   Linear                                             153             138                  15                         

Values are expressed as mean±SD or number of patients (n).

P values refer to comparison between patients with AL and without AL.

AL, anastomotic leakage; ASA, American Society of Anesthesiologist; COA, cervical oesophagogastric anastomosis; COPD, chronic obstructive pulmonary disease; IOA, intrathoracic oesophagogastric anastomosis; SCC, squamous cell carcinoma.

The results of univariate and multivariate analyses are shown in [table 5](#T5){ref-type="table"}, respectively. Multivariable analyses using a stepwise backward model revealed that diabetes mellitus (OR 2.001, p=0.047), surgical pathway (sweet: reference; Ivor Lewis: OR 1.456; McKeown: OR 2.362, p=0.041), surgical procedure (open: reference; minimally invasive: OR 1.770, p=0.049) and anastomotic mode (semimechanical: reference; stapled: OR 1.821; handsewn: OR 2.271, p=0.048) were independent predictors of leakage. Multivariate analyses revealed that the level of anastomotic site may not affect the risk for anastomotic leakage (OR 1.622; 95% CI 0.897 to 2.934, p=0.110).

###### 

Logistic regression analysis identifying predictors for anastomotic leakage

  Characteristics            Univariate   Multivariate                                               
  -------------------------- ------------ ---------------- ------- ---------------- ---------------- -------
  Age \>60 years             1.956        1.017 to 3.762   0.044   1.476            0.797 to 2.732   0.215
  Obesity                    1.686        0.931 to 3.053   0.084   1.320            0.714 to 2.440   0.376
  Alcohol history            1.768        0.966 to 3.237   0.065   1.281            0.718 to 2.284   0.402
  Smoking history            1.835        0.954 to 3.531   0.069   1.456            0.525 to 4.038   0.067
  Comorbidities                                                                                      
   Diabetes mellitus         2.207        1.128 to 4.317   0.021   2.000            1.008 to 3.968   0.047
   Coronary artery disease   1.894        0.915 to 3.919   0.085   1.482            0.682 to 3.221   0.321
   Peptic ulcer disease      1.973        0.859 to 4.535   0.109   1.420            0.565 to 3.567   0.456
  Tumour location (%)                                                                                
   Junction                  1            Reference        0.044   1                Reference        0.154
   Distal oesophagus         1.876        1.016 to 3.462   1.582   0.842 to 2.970                    
  Anastomotic level (%)                                                                              
   IOA                       1            Reference        0.062   1                Reference        0.110
   COA                       1.753        0.974 to 3.155   1.622   0.897 to 2.934                    
  Surgical procedure,%                                                                               
   Open                      1            Reference        0.032   1                Reference        0.049
   Minimally invasive        1.863        1.055 to 3.290   1.770   1.003 to 3.125                    
  Anastomotic mode, %                                                                                
   Semimechanical            1            Reference        0.024   1                Reference        0.048
   Stapled                   2.174        1.070 to 4.416   1.821   0.854 to 3.880                    
   Handsewn                  2.284        1.118 to 4.664   2.271   1.055 to 4.887                    

COA, cervical oesophagogastric anastomosis; IOA, intrathoracic oesophagogastric anastomosis.

Discussion {#s4}
==========

We performed this retrospective study to test the hypothesis that anastomotic level may affect anastomotic leakage occurrence after elective oesophagectomy. Our study revealed similar anastomotic leakage after intrathoracic anastomosis compared with cervical anastomosis. Previous studies have revealed several preoperative predictors of leakage including smoking, hypertension, renal insufficiency and albumin.[@R7] In addition, we specially added all relevant operative covariates into logistic analysis to identify independent risk factors for leakage as an endpoint. Our multivariate analysis indicated that diabetes mellitus, surgical procedures and anastomotic method rather than the level of anastomotic site were all independent predictors of anastomotic leakage after oesophageal cancer surgery.

Unlike the previous reported results,[@R16] we failed to identify the level of anastomotic site as an independent predictor of postoperative anastomotic leakage after adjusting for other confounding factors, although more patients in the COA group developed more anastomotic leakage than those in the IOA group. It is revealed that the level of anastomotic site may not affect the risk for anastomotic leakage. One potential explanation is the variety of definitions used for anastomotic leakage between the previous literatures and present study in which we use the definition from ECCG to grade postoperative leakage.[@R15]

Although the role of anastomotic mode in leakage after oesophagectomy has been investigated widely in recent years, results from relevant literature remain controversial.[@R19] We found that the anastomotic mode is significantly associated with the occurrence of anastomotic leakage. It is possible that the large triangulated opening created with the stapled technique results in decreased early anastomotic obstruction compared with the hand-sewn technique, resulting in decreased anastomotic leakage.[@R18] Our findings is in line with the results from Harustiak's study demonstrating the superiority of stapled to hand-sewn technique in leakage occurrence,[@R18] but in contrast to the earlier publications demonstrating the similar leakage rates between techniques.[@R20]

Our study found patients undergoing oesophagectomy with COA have higher functional morbidity than those with IOA, which is in line with Workum's recent report.[@R23] Potential explanations are that relatively more ischaemia of the tip of the gastric tube in COA likely contributes to an increased incidence of anastomotic leakage,[@R24] strictures[@R25] and dysphagia[@R23] compared with IOA. In our study, however, IOA is associated with a higher reintervention rate than COA, which might be explained by our aggressive attitude towards treatment of intrathoracic anastomotic leakage.

Multivariable analysis in our study suggested that minimally invasive oesophagectomy increased the risk of anastomotic leakage compared with open oesophagectomy. Similar findings have been reported in the previous studies.[@R3] The most important explanation is the adverse impact of forceps grasping during laparoscopic manoeuvre on submucosal blood supply of the stomach.[@R28] Another explanation is that surgeon's learning curve of introducing minimally invasive oesophagectomy,[@R30] even in high-volume centres, is much longer than that of introducing open oesophagectomy regardless of COA or IOA.

Strengths and limitations {#s4a}
-------------------------

The strength of this study is the focus on surgical and anastomotic techniques, the consecutive design and the comparison of a large cohort of patients treated after COA and IOA. There are several limitations in our study that should be mentioned when interpreting our results. First, our study is subject to inherent biases given the retrospective design. Although these preoperative variables between groups were equally distributed, we could not entirely exclude all relevant confounding factors in clinical practice that might influence our results. Second, we only included anastomotic leakage which was indicated explicitly in our medical records rather than evaluate minor leakages as they were uncertain and difficult to diagnose. Third, the findings should be generalised carefully as they were based on a single hospital of traditional Chinese medicine. Also, because surgical invasiveness is completely different between the thoracic anastomosis, so it is necessary to compare the prognosis in addition to short-term postoperative outcomes in the future study.

Conclusions {#s5}
===========

COA was associated with comparable anastomotic morbidity compared with IOA in this study. Surgical and anastomotic techniques rather than the level of anastomotic site were independent predictors of postoperative anastomotic leakage in patients undergoing oesophageal cancer surgery. A randomised controlled trial is warranted to investigate whether these findings can be confirmed prospectively.
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